Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123028) titled 'A multi-center, prospective, observational real-world study evaluating the efficacy and safety of acemetacin sustained-release capsules in the treatment of active axial spondyloarthritis (axSpA)' on April 21.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Chinese People's Liberation Army General Hospital

Condition: Active axial spondyloarthritis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-05-06

Target Sample Size: Observation group:150;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=316348

Dis...